论文部分内容阅读
90％的原发性肝癌病人就诊时已丧失手术机会。目前肝动脉化疗栓塞术(TAE)被证明是非手术治疗中最佳治疗方法,但是在伴有门静脉癌栓,癌肿子节结和癌肿包膜浸润时,效果不佳,本文探讨在TAE基础上加用健脾理气中药,旨在提高肝癌的治疗效果,现就1991～1993年所治疗的22例病例作一总结。 资料与方法 本组资料共有46例肝癌病人,男性39例,女性7例,经临床、AFP、B超、CT或肝动脉造影证实为原发性肝癌,符合1977年全国肝癌协作会议制定的标准。分二组,一组单纯TAE组,共24例,另一组
90% of patients with primary liver cancer have lost surgery when they visit the clinic. At present, hepatic arterial chemoembolization (TAE) has been proved to be the best treatment in non-surgical treatment, but it is not effective when portal vein tumor thrombus, cancerous nodules, and cancer capsule infiltrate. This article discusses the basis of TAE. Added to the use of spleen Qi Chinese medicine, designed to improve the therapeutic effect of liver cancer, is now on the treatment of 22 cases from 1991 to 1993 for a summary. Materials and Methods There were 46 patients with liver cancer, 39 males and 7 females in this group. Primary liver cancer was confirmed by clinical, AFP, B-ultrasonography, CT, or hepatic arterial angiography. It met the criteria set by the National Hepatitis Cancer Collaboration Conference in 1977. . In two groups, a group of simple TAE group, a total of 24 cases, another group